Home Applications 216285 Application 216285
Type NDA
Sponsor EXELTIS USA INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 DROSPIRENONE DROSPIRENONE TABLET, CHEWABLE;ORAL 3.5MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N216285-001 DROSPIRENONE DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29
Orange Book patents# Current patent rows page 1 of 1 · 15 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N216285-001 10179140 2031-06-28 U-2553 2022-07-13 N216285-001 10603281 2031-06-28 U-2553 2022-07-13 N216285-001 10849857 2031-06-28 U-2553 Drug product 2022-07-13 N216285-001 10987364 2031-06-28 Drug product 2022-07-13 N216285-001 11123299 2031-06-28 Drug product 2022-07-13 N216285-001 11291632 2031-06-28 Drug product 2022-07-13 N216285-001 11291633 2031-06-28 Drug product 2022-07-13 N216285-001 11351122 2031-06-28 Drug product 2022-07-13 N216285-001 11413249 2031-06-28 U-2553 2022-08-22 N216285-001 11439598 2031-06-28 Drug product 2022-09-21 N216285-001 11478487 2031-06-28 Drug product 2022-11-04 N216285-001 11504334 2031-06-28 Drug product 2022-12-16 N216285-001 11951213 2031-06-28 U-2553 2024-04-25 N216285-001 12090231 2031-06-28 U-2553 2024-10-09 N216285-001 9603860 2031-06-28 U-2553 2022-07-13
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 84e616aacf4f…2026-08-18 06:07:40 2026-07 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD, RS 2022-06-29 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD, RS 2022-06-29 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD, RS 2022-06-29 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD, RS 2022-06-29 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD, RS 2022-06-29 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD, RS 2022-06-29 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD, RS 2022-06-29 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N216285-001 DROSPIRENONE 3.5MG TABLET, CHEWABLE / ORAL RLD 2022-06-29 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 10 · 400 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N216285-001 10179140 2031-06-28 U-2553 2022-07-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N216285-001 10603281 2031-06-28 U-2553 2022-07-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N216285-001 10849857 2031-06-28 U-2553 Drug product 2022-07-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N216285-001 10987364 2031-06-28 Drug product 2022-07-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N216285-001 11123299 2031-06-28 Drug product 2022-07-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N216285-001 11291632 2031-06-28 Drug product 2022-07-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N216285-001 11291633 2031-06-28 Drug product 2022-07-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N216285-001 11351122 2031-06-28 Drug product 2022-07-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N216285-001 11413249 2031-06-28 U-2553 2022-08-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N216285-001 11439598 2031-06-28 Drug product 2022-09-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N216285-001 11478487 2031-06-28 Drug product 2022-11-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N216285-001 11504334 2031-06-28 Drug product 2022-12-16 84e616aacf4f…2026-09-14 22:38:34 2026-08 N216285-001 11951213 2031-06-28 U-2553 2024-04-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N216285-001 12090231 2031-06-28 U-2553 2024-10-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 N216285-001 9603860 2031-06-28 U-2553 2022-07-13 84e616aacf4f…2026-08-18 06:07:40 2026-07 N216285-001 10179140 2031-06-28 U-2553 2022-07-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N216285-001 10603281 2031-06-28 U-2553 2022-07-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N216285-001 10849857 2031-06-28 U-2553 Drug product 2022-07-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N216285-001 10987364 2031-06-28 Drug product 2022-07-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N216285-001 11123299 2031-06-28 Drug product 2022-07-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N216285-001 11291632 2031-06-28 Drug product 2022-07-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N216285-001 11291633 2031-06-28 Drug product 2022-07-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N216285-001 11351122 2031-06-28 Drug product 2022-07-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N216285-001 11413249 2031-06-28 U-2553 2022-08-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N216285-001 11439598 2031-06-28 Drug product 2022-09-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N216285-001 11478487 2031-06-28 Drug product 2022-11-04 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N216285-001 11504334 2031-06-28 Drug product 2022-12-16 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N216285-001 11951213 2031-06-28 U-2553 2024-04-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N216285-001 12090231 2031-06-28 U-2553 2024-10-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N216285-001 9603860 2031-06-28 U-2553 2022-07-13 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N216285-001 10179140 2031-06-28 U-2553 2022-07-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216285-001 10603281 2031-06-28 U-2553 2022-07-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216285-001 10849857 2031-06-28 U-2553 Drug product 2022-07-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216285-001 10987364 2031-06-28 Drug product 2022-07-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216285-001 11123299 2031-06-28 Drug product 2022-07-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216285-001 11291632 2031-06-28 Drug product 2022-07-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216285-001 11291633 2031-06-28 Drug product 2022-07-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216285-001 11351122 2031-06-28 Drug product 2022-07-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216285-001 11413249 2031-06-28 U-2553 2022-08-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216285-001 11439598 2031-06-28 Drug product 2022-09-21 011fe1cb6892…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents# Document, Submission type, Date table Document Submission type Date 73802 ORIG 2023-03-20 72980 SUPPL 2022-12-21 71502 ORIG 2022-06-30 71493 ORIG 2022-06-30